Publication | Open Access
Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study
50
Citations
29
References
2017
Year
Orexigen Therapeutics, Inc.
| Year | Citations | |
|---|---|---|
Page 1
Page 1